Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s41403-020-00127-5 http://scihub22266oqcxt.onion/10.1007/s41403-020-00127-5 C7303936!7303936!38624370     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ä-/-ä 2020 ; 5 (2): 229-32 Nephropedia Template TP {{tp|p=38624370|t=2020. Developing a Point-of-Care Molecular Test to Detect SARS-CoV-2 |pdf=|usr=}}{{38624370}} gab.com Text Developing a Point-of-Care Molecular Test to Detect SARS-CoV-2 JO: ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=38624370 #FOAvip There is a need for widespread testing in India to stop the spread of the novel coronavirus in the population. While RT-PCR is the recommended diagnostic technique, its use is limited to well-equipped laboratories due to the need for specialized instrumentation, reagents and trained personnel. Immunodiagnostic tests are not yet recommended by the WHO for diagnosing active infections. There is a strong need for developing point-of-care molecular tests. Based on our past experience with paperfluidic devices for diagnosing bacterial infections by molecular tests, we propose the development of a diagnostic test for COVID-19. As a platform technology, it could be adapted to other viral outbreaks in future. Twit Text FOAVip Developing a Point-of-Care Molecular Test to Detect SARS-CoV-2 ????ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=38624370 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=38624370 #FOAvip English Wikipedia <ref>{{Cite pmid|38624370}}</ref> Developing a Point-of-Care Molecular Test to Detect SARS-CoV-2 #MMPMID38624370 Paul D; Naik P; Roy S ä-/-ä 2020[]; 5 (2): 229-32 PMID38624370show ga There is a need for widespread testing in India to stop the spread of the novel coronavirus in the population. While RT-PCR is the recommended diagnostic technique, its use is limited to well-equipped laboratories due to the need for specialized instrumentation, reagents and trained personnel. Immunodiagnostic tests are not yet recommended by the WHO for diagnosing active infections. There is a strong need for developing point-of-care molecular tests. Based on our past experience with paperfluidic devices for diagnosing bacterial infections by molecular tests, we propose the development of a diagnostic test for COVID-19. As a platform technology, it could be adapted to other viral outbreaks in future. äDeveloping a Point-of-Care Molecular Test to Detect SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing